Recurrent acute pancreatitis study and treatment
Part of Digestive system clinical trials.
This trial follows the natural course of recurrent acute pancreatitis and tests how well treatments work for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had acute pancreatitis more than once.
- You are willing and able to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a procedure called ERCP can help find and treat the cause of recurrent pancreatitis that remains unexplained after standard tests.
This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.
This trial is studying whether stopping alcohol and quitting smoking can help keep acute pancreatitis from returning. It’s for people whose pancreatitis happened because of alcohol, and who smoke every day.
This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.
This early-phase study tests whether simvastatin can improve patient-reported symptoms in people with recurrent acute or chronic pancreatitis. It’s meant to see if the medicine is tolerable and helps with how you feel day to day.
This study collects health information and samples over time from people with chronic pancreatitis to learn more about the disease and improve care. It may include endoscopic procedures, which use a thin tube to look at the pancreas.
Hear when a new Cohort Studies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.